This study investigated how supplementation with ARG, CIT or their combination influences Mtb survival in human and murine, primary macrophages and cell line, both in naïve and IFNγ-activated states, and evaluated whether these amino acids can enhance the activity of anti-TB drugs, isoniazid (INH) and rifampicin (RIF). The gene discussed is IFNG; the disease is tuberculosis.